Dextro-amphetamine diminishes negative symptoms in schizophrenia

Area of Science:

• Psychiatry
• Neuroscience
• Pharmacology

Background:

• Schizophrenia is a complex mental disorder characterized by positive, negative, and cognitive symptoms.
• Negative symptoms, including apathy and social withdrawal, are often persistent and difficult to treat.
• The role of dopamine and other neurotransmitters in schizophrenia pathophysiology is under investigation.

Purpose of the Study:

• To investigate the effects of dextro-amphetamine on negative symptoms and mood in patients with schizophrenia.
• To examine the relationship between dextro-amphetamine response and pimozide treatment in schizophrenia patients.
• To evaluate the validity of the Type II model for irreversible negative symptoms in schizophrenia.

Main Methods:

• Thirty patients diagnosed with schizophrenia participated in the study.
• Intravenous dextro-amphetamine was administered to patients both on and off pimozide medication.
• Correlational analyses were performed to assess the relationship between symptom changes and medication status.

Main Results:

• Intravenous dextro-amphetamine demonstrated a partial therapeutic effect on negative symptoms and depressed mood in schizophrenia.
• A significant positive correlation was observed between improvement in negative symptoms during dextro-amphetamine challenge and subsequent improvement during pimozide treatment.
• The findings do not support the Type II model of irreversible negative symptoms in this patient cohort.

Conclusions:

• Negative symptoms in schizophrenia may be influenced by state-dependent alterations in the dopamine system.
• Noradrenergic mechanisms could also play a role in the observed changes in negative symptoms.
• These findings suggest potential therapeutic avenues for managing negative symptoms in schizophrenia.